Dysregulation of genes involved in the long-chain fatty acid transport in pancreatic ductal adenocarcinoma


Here are the Dysregulation of genes involved in the long-chain fatty acid transport in pancreatic ductal adenocarcinoma journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.

Autonomic dysregulation of blood pressure, dysregulation of genes involved in the long chain fatty acid, dysregulation of dopamine, dysregulation of cholesterol metabolism, dysregulation of genes involved in ovarian, dysregulation of genes involved in autism, dysregulation of genes involved in pancreatic cancer.

Dysregulation of genes involved in the long-chain fatty acid transport in pancreatic ductal adenocarcinoma

BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is an aggressive lethal malignancy with limited options for treatment and a 5-year survival rate of 11% in the United States. As for other types of tumors, such as colorectal cancer, aberrant de novo lipid synthesis and reprogrammed lipid metabolism have been suggested to be associated with PDAC development and progression. AIM To identify the possible involvement of lipid metabolism in PDAC by analyzing in tumoral and non-tumoral tissues the expression level of the most relevant genes involved in the long-chain fatty acid (FA) import into cell. METHODS A gene expression analysis of FASN, CD36, SLC27A1, SLC27A2, SLC27A3, SLC27A4, SLC27A5, ACSL1, and ACSL3 was performed by qRT-PCR in 24 tumoral PDAC tissues and 11 samples from non-tumoral pancreatic tissues obtained via fine needle aspiration or via surgical resection. The genes were considered significantly dysregulated between the groups when the p value was < 0.05 and the f old change (FC) was ≤ 0.5 and ≥ 2. RESULTS We found that three FA transporters and two long-chain acyl-CoA synthetases genes were significantly upregulated in the PDAC tissue compared to the non-tumoral tissue: SLC27A2 (FC = 5.66; P = 0.033), SLC27A3 (FC = 2.68; P = 0.040), SLC27A4 (FC = 3.13; P = 0.033), ACSL1 (FC = 4.10; P < 0.001), and ACSL3 (FC = 2.67; P = 0.012). We further investigated any possible association between the levels of the analyzed mRNAs and the specific characteristics of the tumors, including the anatomic location, the lymph node involvement, and the presence of metastasis. A significant difference in the expression of SLC27A3 (FC = 3.28; P = 0.040) was found comparing patients with and without lymph nodes involvement with an overexpression of this transcript in 17 patients presenting tumoral cells in the lymph nodes. CONCLUSION Despite the low number of patients analyzed, these preliminary results seem to be promising. Addressing lipid metabolism through a broad strategy could be a beneficial way to treat this malignancy. Future in vitro and in vivo studies on these genes may offer important insights into the mechanisms linking PDAC with the long-chain FA import pathway. © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.

Authors : Poenaru R.C.; Milanesi E.; Niculae A.M.; Dobre A.-M.; Vladut C.; Ciocîrlan M.; Balaban D.V.; Herlea V.; Dobre M.; Hinescu M.E.

Source : Baishideng Publishing Group Inc

Article Information

Year 2025
Type Article
DOI 10.4251/wjgo.v17.i1.98409
ISSN 19485204
Volume 17

You can download the article here


If You have any problem, contact us here


Support Us:

Download Now Buy me a coffee Request Paper Here